Loading...
Efficacy of Abiraterone and Enzalutamide in Pre- and Postdocetaxel Castration-Resistant Prostate Cancer: A Trial-Level Meta-Analysis
We examined the comparative efficacies of first-line abiraterone and enzalutamide in pre- and postdocetaxel settings in castration-resistant prostate cancer (CRPC) through a trial level meta-analysis. A mixed method approach was applied to 19 unique studies containing 17 median overall survival (OS)...
Na minha lista:
| Udgivet i: | Prostate Cancer |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hindawi
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5735648/ https://ncbi.nlm.nih.gov/pubmed/29359049 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/8560827 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|